Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11981
-
11982
Individual data 2020.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11983
Household data 2022.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11984
Persons with epilepsy data 2022.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11985
Ivermectin coverage in 2019 and 2021.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11986
Individual data 2022.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11987
Household data 2020.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11988
Persons with epilepsy data 2020.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
11989
PRISMA flowchart of the included studies.
Published 2025“…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
-
11990
Characteristics of Included Studies.
Published 2025“…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
-
11991
-
11992
-
11993
-
11994
-
11995
-
11996
-
11997
RpoS and Indole Signaling Control the Virulence of <i>Vibrio anguillarum</i> towards Gnotobiotic Sea Bass (<i>Dicentrarchus labrax</i>) Larvae
Published 2014“…Deletion of <i>rpoS</i> resulted in increased expression of the indole biosynthesis gene <i>tnaA</i> and in increased production of indole. Both <i>rpoS</i> deletion and the addition of exogenous indole (50–100 µM) resulted in decreased biofilm formation, exopolysaccharide production (a phenotype that is required for pathogenicity) and expression of the exopolysaccharide synthesis gene <i>wbfD</i>. …”
-
11998
Presentation_1_Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.PPTX
Published 2022“…</p>Results<p>The percentage of males was 50 and 66% and the mean age was 65.16 ± 14.24 and 66.33 ± 13.48 years among patients and controls respectively (mean ± SD, p = 0.78). …”
-
11999
Cleaved caspase-9 of regional brain homogenates obtained at 3, 4, 5, and 9 hours after ROSC by Western blot analysis.
Published 2021“…<p>At four and five hours after ROSC, only the hypothermia + VPA group showed significantly decreased cleaved caspase-9 levels compared to the normothermia group both in the hippocampus (A) and the cerebellar vermis (B). …”
-
12000